Abstract | AIMS: Acute neutropenia induced by antibiotics is a rare side effect of this frequently prescribed class of drugs. We aim to find similarities and differences between reported cases. METHODS: Through a database search (PubMed, 1968-2020), we identified published case reports and extracted, among other data, patient demographics, duration of treatment with the respective agent, and duration of recovery. RESULTS: Overall, 83 cases were included. Neutropenia developed after a median (min-max) of 21 (17.5-28.5) days of treatment and was resolved after a median (min-max) of 6 (3.0-8.75) days. Vancomycin and ceftaroline emerged as the two most commonly described antibiotics. In 51.8% of cases, the suspected antibiotic was discontinued; in 37.4% of cases, it was substituted by another agent. Only three case reports mentioned death as a result of neutropenia. The use of granulocyte colony-stimulating growth factors (CSFs) shortened the duration of neutropenia and improved outcome for patients' health. CONCLUSION:
Neutropenia induced by antibiotics remains a rare or rarely reported side effect. Long-term and high-dose treatment regimens expose a higher risk of development. Thus, regular full blood counts are advised during therapy.
|
Authors | Julian M Holz, Alon V Chevtchenko, Aleksandra Aitullina |
Journal | British journal of clinical pharmacology
(Br J Clin Pharmacol)
Vol. 88
Issue 5
Pg. 1978-1984
(05 2022)
ISSN: 1365-2125 [Electronic] England |
PMID | 34897762
(Publication Type: Case Reports, Journal Article, Review, Systematic Review)
|
Copyright | © 2021 British Pharmacological Society. |
Chemical References |
- Anti-Bacterial Agents
- Granulocyte Colony-Stimulating Factor
|
Topics |
- Anti-Bacterial Agents
(adverse effects)
- Drug-Related Side Effects and Adverse Reactions
- Granulocyte Colony-Stimulating Factor
(adverse effects)
- Humans
- Neutropenia
(chemically induced)
|